Morgan Stanley analyst James Faucette weighs in on shares of Cisco Systems, Inc. (NASDAQ:CSCO) ahead of fourth-quarter results.
Yesterday, Morgan Stanley analyst Brian Nowak attended Amazon.com, Inc.
Endo International plc – Ordinary Shares (NASDAQ:ENDP) just raised the price on its pipeline drug, Vasostrict, a polypeptide hormone indicated to increase blood …
Morgan Stanley analyst James Faucette reiterates an Overweight rating with a $65 price target on shares of QUALCOMM, Inc. (NASDAQ:QCOM), following the company’s latest …
Analyst David Risinger from Morgan Stanley presented five questions he would like to see answered in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) upcoming earnings report …
Drug giant Celgene Corporation (NASDAQ:CELG) just came in strong this second quarter, thanks to great performances from pipeline drugs lymphoma treating Revlimid and Pomalyst, …
New insights emerge in the biotech sector as Valeant Pharmaceuticals Intl Inc (NYSE:VRX) received a Complete Response Letter (CRL) from the FDA on its eye …
Following Cisco Systems, Inc. (NASDAQ:CSCO)’s CiscoLive!
Morgan Stanley analysts separately explain why they are cautious on electric car giant Tesla Motors Inc (NASDAQ:TSLA) and entertainment giant Walt Disney Co (NYSE:DIS), as more questions arise …
In a research report issued Thursday, Morgan Stanley analyst Kathryn Huberty shared her expectations on International Business Machines Corp. (NYSE:IBM) as the the next …
